Article
Cell Cycle-Related Kinase: A Novel Candidate Oncogene in Human Glioblastoma
12 Jun 2007
Abstract excerpt
BACKGROUND: Median survival for patients with glioblastoma multiforme, the most aggressive glioma, is only 12-15 months, despite multimodal treatment that includes surgery, chemotherapy, and radiotherapy. Thus, identification of genes that control the progression of glioblastoma multiforme is crucial for devising new therapies. We investigated the involvement of cell cycle-related kinase (CCRK), a novel protein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
